NTRB: financial statements from SEC — TradeAlmanac

NTRB

Nutriband Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Jan 31, 2026	Jan 31, 2025
Revenue	2m	2m
Cost of revenue	1m	1m
Research and development	2m	3m
Selling, general and administrative	7m	4m
Operating expenses	10m	12m
Operating income	−8m	−10m
Pre-tax income	−8m	−10m
Net income	−8m	−10m
Earnings per share	−2.58	−0.99
Earnings per share, diluted	−2.58	−0.99
Weighted average shares	12m	11m
Weighted average shares, diluted	12m	11m

Balance sheet

Metric	Apr 30, 2026	Jan 31, 2026	Oct 31, 2025	Jul 31, 2025	Apr 30, 2025	Jan 31, 2025	Oct 31, 2024	Aug 31, 2024
Cash and equivalents	4m	5m	5m	7m	3m	4m	6m	—
Receivables	2,632	118,404

Cash flow

Metric	Jan 31, 2026	Jan 31, 2025
Operating cash flow	−5m	−5m
Depreciation and amortisation	193,797	285,054
Share-based compensation	3m	1m
Capital expenditure	5,324	92,043
Investing cash flow	−5,324	−92,043
Financing cash flow	5m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)